-
Specialties
AL Amyloidosis, lymphoma, leukemia, multiple myeloma, thrombosis, hemostasis, autologous stem cell transplantation.
-
Departments
My Contact Information
- 617.638.6428
-
Primary Location
830 Harrison Avenue
3rd Floor
Boston, MA 02118
More About Me
J Mark Sloan, MD, is a hematologist at Boston Medical Center (BMC), specializing in benign and malignant blood disorders, including AL Amyloidosis, lymphoma, leukemia, multiple myeloma, and thrombosis. Dr. Sloan is also an associate professor of Medicine at Boston University Chobanian & Avedisian School of Medicine, a member of the Boston University-BMC Cancer Center, and a member of the Boston
... University Amyloidosis Center. Dr. Sloan received his medical degree and completed a fellowship at the Yale School of Medicine. He went on to complete a fellowship in hematology/oncology at Dana-Farber Cancer Institute and Massachusetts General Hospital. Dr. Sloan is a member of the Evans Center for Interdisciplinary Biomedical Research at Boston University, and his research interests focus on primary (AL) amyloidosis and HTLV-1 associated leukemia/lymphoma (ATLL).
-
Administrative Title
Associate Professor of Medicine, Boston University Chobanian and Avedisian School of Medicine. Member, Boston University-BMC Cancer Center. Member, Boston University Amyloidosis Center. -
Education
Yale University School of Medicine, 2001 -
Residency
Internal Medicine, Yale-New Haven Medical Center, 2001-2004 -
Fellowship
Hematology and Medical Oncology, Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute, 2005-2008 -
Board Certifications
Internal Medicine, Medical Oncology, and Hematology, American Board of Internal Medicine Certified in American Board of Internal Medicine -
Special Interests
AL Amyloidosis, lymphoma, leukemia, multiple myeloma, thrombosis, hemostasis, autologous stem cell transplantation.
Affiliations
Boston University is a leading private research institution with two primary campuses in the heart of Boston and programs around the world.